NL-OMON37485已完成3 期
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetes A 26-week double-blind placebo-controlled randomised multicentre, multinational parallel-group trial - NN2211-3917
ovo Nordisk0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Diagnosed with type 2 diabetes for at least 180 days prior to screening
- •-HbA1c 7.0-10.0% (both inclusive)
- •-Body mass index (BMI) 20.0-45.0 kg/m2 (both inclusive)
- •-Age 18-80 years (both inclusive)
排除标准
- •Female who is pregnant, breast-feeding or intend to become pregnant
- •Recurrent severe hypoglycaemic episodes or hypoglycaemic unawareness
- •Treatment with glucose-lowering agent(s) other than stated in the inclusion criteria in a period of 12 weeks prior to screening
- •Impaired liver or renal function
- •Uncontrolled treated or untreated hypertension (SBP >=180 mmHg and/or DBP >=100 mmHg)
- •Any clinically significant disorder, except for conditions associated with type 2 diabetes history which in the investigator*s opinion could interfere with results of the trial
- •Known or suspected abuse of alcohol or narcotics
研究者
相似试验
进行中（未招募）
不适用
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-002696-41-FIovo Nordisk A/S446
进行中（未招募）
不适用
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2011-002696-41-DEovo Nordisk A/S446
已完成
3 期
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCTRI/2012/10/003072ovo Nordisk AS69
进行中（未招募）
不适用
The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersDiabetes Mellitus, Type 2EUCTR2011-002696-41-NLovo Nordisk A/S446
进行中（未招募）
1 期
Efficacy and safety of liraglutide versus placebo as add-on to existing diabetes medication in subjects with type 2 diabetes and moderate renal impairmentDiabetes Mellitus, Type 2EUCTR2011-002968-24-GBovo Nordisk A/S277